Study 2: SELECT Trial Duration : 208 weeks (4 years) Findings : Semaglutide users sustained a weight reduction of 10.2% from baseline versus 1.5% with placebo
Many users report feeling the effects of alcohol faster and more strongly while on semaglutide
Strictly for in-vitro research use only
Other weight loss drugs included phentermine (sold as Lomaira, among others), bupropion (Aplenzin, among others), topiramate (Topamax, among others), zonisamide (Zonegran, among others), amphetamine (Azendys, among others), and naltrexone (brand name Relistor, among others)
Sultn explains
You should feel safe, heard, and understood in the exam room